Christian Mueller
Corporate Officer/Principal presso IMMUTEP LIMITED
Profilo
Christian Mueller is currently working as the SVP-Regulatory & Strategy at Immutep Ltd.
Previously, he worked as a Project Manager at Medical Enzymes AG.
He graduated from the Technical University of Berlin.
Posizioni attive di Christian Mueller
| Società | Posizione | Inizio |
|---|---|---|
| IMMUTEP LIMITED | Corporate Officer/Principal | - |
Precedenti posizioni note di Christian Mueller
| Società | Posizione | Fine |
|---|---|---|
Medical Enzymes AG
 Medical Enzymes AG Medical/Nursing ServicesHealth Services Medical Enzymes AG is a privately held innovative biopharmaceutical company with a focus on therapeutically useful enzymes. The company has developed a new product family based on amino acid depleting enzymes. This unique approach is highly effective against cancer - the major target market of Medical Enzymes AG. Medical Enzymes business strategy focuses on the clinical development of therapeutic enzymes until clinical proof of concept and to commercialize those products through collaboration with selected pharmaceutical partners. | Corporate Officer/Principal | - |
Formazione di Christian Mueller
| Technical University of Berlin | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| IMMUTEP LIMITED | Health Technology |
| Aziende private | 1 |
|---|---|
Medical Enzymes AG
Medical Enzymes AG Medical/Nursing ServicesHealth Services Medical Enzymes AG is a privately held innovative biopharmaceutical company with a focus on therapeutically useful enzymes. The company has developed a new product family based on amino acid depleting enzymes. This unique approach is highly effective against cancer - the major target market of Medical Enzymes AG. Medical Enzymes business strategy focuses on the clinical development of therapeutic enzymes until clinical proof of concept and to commercialize those products through collaboration with selected pharmaceutical partners. | Health Services |
- Borsa valori
- Insiders
- Christian Mueller
